Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Patient safety

Authorisation status

ATC code

Marketing authorisation date

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

Medicine type

Therapeutic area

Last updated

First published

59 results

Sort by

List item

Human medicine European public assessment report (EPAR): Varuby

rolapitant, Vomiting; Nausea; Cancer
Date of authorisation: 19/04/2017, , Revision: 3, Withdrawn, Last updated: 02/03/2020
List item

Human medicine European public assessment report (EPAR): Vibativ

telavancin, Pneumonia, Bacterial; Cross Infection
Date of authorisation: 02/09/2011, , Revision: 10, Withdrawn, Last updated: 16/05/2018
List item

Human medicine European public assessment report (EPAR): Vitekta

elvitegravir, HIV Infections
Date of authorisation: 13/11/2013, , Revision: 4, Withdrawn, Last updated: 29/05/2017
List item

Human medicine European public assessment report (EPAR): Xigris

drotrecogin alfa (activated), Sepsis; Multiple Organ Failure
Date of authorisation: 22/08/2002, , Revision: 13, Withdrawn, Last updated: 21/02/2012
List item

Human medicine European public assessment report (EPAR): Zinbryta

daclizumab, Multiple Sclerosis
Date of authorisation: 01/07/2016, , Revision: 8, Withdrawn, Last updated: 28/06/2018
List item

Human medicine European public assessment report (EPAR): Zontivity

vorapaxar sulfate, Myocardial Infarction
Date of authorisation: 19/01/2015, , Revision: 2, Withdrawn, Last updated: 20/09/2017
List item

Human medicine European public assessment report (EPAR): Zurampic

lesinurad, Hyperuricemia
Date of authorisation: 18/02/2016, , Revision: 4, Withdrawn, Last updated: 31/07/2020
List item

Human medicine European public assessment report (EPAR): Zynquista

Sotagliflozin, Diabetes Mellitus, Type 1
Date of authorisation: 26/04/2019, , Revision: 3, Withdrawn, Last updated: 16/08/2022
List item

Human medicine European public assessment report (EPAR): Zynteglo

Autologous CD34+ cell enriched population that contains haematopoietic stem cells transduced with lentiviral vector encoding the βA-T87Q-globin gene, beta-Thalassemia
Date of authorisation: 29/05/2019, , , , , Revision: 5, Withdrawn, Last updated: 30/11/2022